Todd S. Thomson

Insider Reports History

Reporting-owner location: Beverly Hills, CA
Latest reporting-owner signature: /s/ Paul Lytle, Attorney-in-Fact
Transaction source note: Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Todd S. Thomson

Form 4 holding Director, 10%+ Owner

ACTUATE THERAPEUTICS, INC.

Security class: Common Stock
Shares / value: 873,033
Estimated value: $6,477,904
Report date: 05 Jan 2026
Price: $7.42
Ownership: By Kairos Venture Opportunities I, L.P.

Form 4 holding Director, 10%+ Owner

ACTUATE THERAPEUTICS, INC.

Security class: Common Stock
Shares / value: 904,795
Estimated value: $5,247,811
Report date: 05 Jan 2026
Price: $5.80
Ownership: By Kairos Venture Partners II, L.P.

Form 4 holding Director, 10%+ Owner

ACTUATE THERAPEUTICS, INC.

Security class: Common Stock
Shares / value: 321,781
Estimated value: $2,387,615
Report date: 05 Jan 2026
Price: $7.42
Ownership: By Kairos SPV Fund, LLC

Form 4 holding Director, 10%+ Owner

ACTUATE THERAPEUTICS, INC.

Security class: Common Stock
Shares / value: 254,735
Estimated value: $1,890,133
Report date: 05 Jan 2026
Price: $7.42
Ownership: By Kairos-Actuate SPV, L.P.

Form 4 holding Director

ZOOZ Strategy Ltd.

Security class: Ordinary Shares
Shares / value: 846,154
Estimated value: $321,538
Report date: 18 Mar 2026
Price: $0.3800
Ownership: Direct

Form 4 holding Director

Chardan NexTech Acquisition 2 Corp.

Security class: Common Stock, par value $0.0001
Shares / value: 22,000
Estimated value: $94,160
Report date: 10 Aug 2021
Price: $4.28
Ownership: Direct

Form 4 holding Director

ZOOZ Strategy Ltd.

Security class: Ordinary Shares
Shares / value: 100,000
Estimated value: $38,000
Report date: 18 Mar 2026
Price: $0.3800
Ownership: By Headwaters Capital LLC

Form 4 holding Director, 10%+ Owner

ACTUATE THERAPEUTICS, INC.

Security class: Stock Options
Shares / value: 15,000
Estimated value
Report date: 21 May 2026
Price
Ownership: Direct
Underlying class: Common Stock
Underlying amount

Insider Reports Filed by Todd S. Thomson

4 ACTU

ACTUATE THERAPEUTICS, INC.

Report period: 21 May 2026
Transactions: 1
Transaction value: $0
Accepted by SEC: 22 May 2026, 16:14
Role: Director, 10%+ Owner
Next action: Open filing details

3 ZOOZ

ZOOZ Strategy Ltd.

Report period: 18 Mar 2026
Transactions: 0
Transaction value: $0
Accepted by SEC: 18 Mar 2026, 07:34
Role: Director
Next action: Open filing details

4 ACTU

ACTUATE THERAPEUTICS, INC.

Report period: 05 Jan 2026
Transactions: 1
Transaction value: -$1,624,000
Accepted by SEC: 07 Jan 2026, 12:45
Role: Director, 10%+ Owner
Next action: Open filing details

4 ACTU

ACTUATE THERAPEUTICS, INC.

Report period: 22 May 2025
Transactions: 1
Transaction value: $0
Accepted by SEC: 23 May 2025, 16:37
Role: Director, 10%+ Owner
Next action: Open filing details

4 ACTU

ACTUATE THERAPEUTICS, INC.

Report period: 12 Aug 2024
Transactions: 22
Transaction value: +$5.28
Accepted by SEC: 16 Aug 2024, 21:12
Role: Director, 16.4% Owner
Next action: Open filing details

3 ACTU

ACTUATE THERAPEUTICS, INC.

Report period: 12 Aug 2024
Transactions: 0
Transaction value: $0
Accepted by SEC: 12 Aug 2024, 18:57
Role: Director, 16.4% Owner
Next action: Open filing details

3 DFLI

Chardan NexTech Acquisition 2 Corp.

Report period: 10 Aug 2021
Transactions: 0
Transaction value: $0
Accepted by SEC: 10 Aug 2021, 21:55
Role: Director
Next action: Open filing details

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .